Pharmaceutical Track and Trace Solutions
Serialization, aggregation and traceability software for pharmaceutical manufacturers, CMOs/CDMOs and MAHs operating across regulated global markets.
Antares Vision Group supports pharmaceutical track and trace programs across the packaging and supply chain execution layers: from line-level serialization and aggregation to site management, enterprise traceability and regulatory connectivity. The result is a validated architecture that helps manufacturers assign a unique identity to each drug pack, build digital packaging hierarchies, manage serialized events and exchange compliance data with trading partners and regulatory systems.
A pharmaceutical track and trace system is not only a packaging-line technology. It is a multi-level architecture connecting serialization hardware, vision verification, aggregation, site-level software, enterprise systems and market-specific regulatory connectivity.
What Is Pharmaceutical Track and Trace?
Pharmaceutical track and trace is the operational capability to identify, verify and reconstruct the movement history of drug products across the supply chain. It combines item-level serialization, aggregation data and event-based traceability to create an auditable chain of custody from manufacturing and packaging to distribution and dispensing.
A pharmaceutical track and trace solution connects packaging line hardware with serialization software, plant and enterprise systems, ERP/MES data and external regulatory or trading partner networks. It helps pharmaceutical companies manage compliance requirements while improving visibility over serialized products, batches, shipments and exceptions.
Serialization gives each pack its unique identity. Aggregation links that identity to cases and pallets. Track and trace records what happens to those identities across manufacturing, packaging, warehousing, shipping, verification and decommissioning events.
Serialization, Aggregation and Track & Trace: What Is the Difference?
Although often used together, serialization, aggregation and track and trace describe different layers of the same traceability program.
| Layer | Role in pharmaceutical traceability | Typical scope |
| Serialization | Assigns and verifies a unique identifier on each saleable unit, usually encoded in a 2D DataMatrix with product code, serial number, batch and expiry data. | Packaging line; print and verify; rejection management. |
| Aggregation | Creates parent-child relationships between serialized units, bundles, cases and pallets, enabling higher-level scanning and shipment handling. | Line, case packing, palletizing, manual or automated aggregation stations. |
| Track and trace | Manages serialized data, aggregation hierarchies, EPCIS or market-specific events, regulatory reporting and trading partner exchange. | Site, enterprise, supply chain and regulatory connectivity. |
This distinction is important for solution design. A line-level serialization system may be sufficient for a single packaging line, while a full pharmaceutical track and trace solution extends across sites, markets and trading partners.
How a Pharmaceutical Track and Trace System Works
A track and trace system works through a sequence of connected data and packaging operations. Each step must be synchronized with production orders, master data, batch records, packaging formats and the regulatory requirements of the target market.
| Step | Process | What happens |
| 1 | Serial number management | Serial numbers are generated, requested or received according to market rules and enterprise governance. |
| 2 | Line-level serialization | Codes are printed, read and verified on each saleable unit at packaging line speed; non-conforming packs are rejected. |
| 3 | Aggregation | Parent-child relationships are created between items, bundles, cases and pallets through manual or automated workflows. |
| 4 | Commissioning and event capture | Serialized units and aggregation hierarchies are associated with batch, production and packaging events. |
| 5 | Reporting, exchange and verification | Events are reported to regulatory systems or exchanged with trading partners, supporting shipment, receipt, verification, recall and decommissioning processes. |
Track and Trace Software: From Line Level to Enterprise Traceability
Pharmaceutical track and trace software is the application layer that connects packaging operations with site, enterprise and external compliance requirements. In a typical architecture, it is structured across multiple levels:
| Level | Function | Main users and decisions |
| L1/L2 – Line and machine level | Controls printers, cameras, reject devices, serialization stations and aggregation equipment. Manages print-and-verify operations and line execution. | Packaging engineering, production, OEMs, system integrators. |
| L3 – Site level | Coordinates serialization and aggregation across multiple lines, manages batch execution, rework, warehouse operations and site-level reporting. | Packaging site, QA, operations, serialization managers. |
| L4 – Enterprise level | Manages serial number pools, multi-site governance, ERP/MES integration, master data alignment and market-specific compliance workflows. | Corporate serialization teams, IT/OT, supply chain, regulatory compliance, MAHs. |
| L5 / External systems | Represents regulatory repositories, national systems, government portals or trading partner networks used for compliance and data exchange. | Regulators, trading partners, distributors, wholesalers, dispensers. |
This multi-level structure reflects how pharmaceutical serialization projects are implemented in practice. Hardware and line integration are critical at packaging level, while enterprise track and trace software becomes central when the same manufacturer must coordinate multiple sites, CMOs, markets and regulatory connections.
Key software capabilities
• Serial number generation, import, allocation and lifecycle management.
• Print-and-verify control with integrated vision inspection of 1D/2D codes and human-readable data.
• Manual and automated aggregation workflows for bundles, cases and pallets.
• Rework, exception handling, decommissioning and recommissioning operations.
• EPCIS-compatible event management and trading partner data exchange.
• ERP/MES integration for master data, production orders, batch data and shipment information.
• Dashboards for serialization status, regulatory reporting, line performance and compliance exceptions.
• Validation support for GxP environments, including IQ/OQ/PQ documentation where applicable.
Designing a Track and Trace Solution for Pharmaceutical Packaging
A track and trace solution should be designed according to the manufacturer’s packaging formats, line configuration, market scope, product portfolio, CMO/CDMO network and IT landscape. The right architecture may range from a single line serialization upgrade to a global enterprise platform for multi-site serialization and regulatory reporting.
At packaging line level, serialization and aggregation systems can be integrated into new or existing equipment, either directly or in cooperation with OEMs and system integrators. At site and enterprise level, track and trace software is typically selected and governed by pharmaceutical manufacturers, CMOs/CDMOs or MAHs, because it involves compliance strategy, ERP integration, serial number governance, market reporting and trading partner data exchange.
Key design decisions
• Regulatory scope: which markets require serialization, aggregation, reporting, verification or EPCIS data exchange.
• Line integration: new packaging line, OEM machine integration, retrofit or revamp of existing equipment.
• Aggregation model: manual aggregation workstations, semi-automated case aggregation or fully automated case and pallet aggregation.
• Software level: line-level only, site-level serialization, enterprise traceability or complete multi-level architecture.
• Deployment model: on-premise, cloud or hybrid, depending on IT policy, validation strategy and connectivity requirements.
• ERP/MES integration depth: master data exchange only, or full integration with production orders, batch records and shipment processes.
• Validation approach: documentation, testing and change control needed for GxP-compliant deployment and future upgrades.
• Trading partner connectivity: direct integration, hub model or market-specific exchange according to DSCSA, EU FMD and other requirements.
Pharmaceutical Track and Trace Requirements Across Global Markets
Pharmaceutical serialization and traceability requirements are now established in many regulated markets, but they are not identical from country to country. Some regulations focus on pack authentication and decommissioning; others require aggregation, supply chain event exchange, government reporting or trading partner interoperability.
In the United States, DSCSA is built around electronic, interoperable product tracing and verification across authorized trading partners. EPCIS is widely used to support standardized data exchange, but the architecture is based on interoperable exchange rather than a single national repository. In the European Union, the Falsified Medicines Directive focuses on pack-level authentication through a unique identifier and an anti-tampering device, with verification and decommissioning through the European and national medicines verification system. Aggregation is not a general EU FMD requirement, although manufacturers often implement it to support other markets and operational efficiency.
| Market or framework | Main focus for manufacturers | Implementation note |
| DSCSA – United States | Serialized product tracing, verification and interoperable data exchange with authorized trading partners. | EPCIS-based exchange is commonly used for standardized transaction data. |
| EU FMD – European Union | Unique identifier, anti-tampering device, repository upload, verification and decommissioning. | Aggregation is not generally mandated by EU FMD but may be used for other markets or operations. |
| GS1 EPCIS / CBV | Standardized capture and exchange of event data describing what, when, where and why in the supply chain. | Useful for DSCSA, partner exchange and global traceability architectures. |
| Other regulated markets | Market-specific serialization, aggregation, reporting and verification requirements. | Requirements vary by country and must be configured according to current local rules. |
For multinational manufacturers and CMOs/CDMOs, the practical challenge is to manage these different requirements in one coherent serialization and traceability architecture, reducing duplication while maintaining local market compliance.
Pharmaceutical Track and Trace Solutions by Antares Vision Group
Antares Vision Group provides pharmaceutical track and trace solutions covering the full serialization and traceability stack: line hardware, vision verification, aggregation systems, site-level software, enterprise traceability and regulatory connectivity. This integrated approach helps manufacturers manage serialized products from the packaging line to the wider supply chain.
The Antares Vision Group platform is designed to support pharmaceutical manufacturers, CMOs/CDMOs and MAHs that need a scalable, validated and flexible track and trace architecture across multiple packaging lines, sites and markets. It combines operational control at line level with software capabilities for serialization lifecycle management, aggregation, EPCIS-compatible event handling, ERP/MES integration, regulatory reporting and exception management.
Platform capabilities
• Line-level serialization with print, inspection, verification and rejection control.
• Manual, semi-automatic and automatic aggregation for item, bundle, case and pallet hierarchies.
• Site-level management of batches, lines, rework operations, warehouse events and serialization exceptions.
• Enterprise traceability for serial number governance, multi-site coordination and market-specific workflows.
• EPCIS-compatible event management for supply chain visibility and trading partner data exchange.
• Integration with ERP/MES systems and packaging equipment through validated interfaces and project-specific engineering.
• Deployment models adapted to customer IT and validation requirements, including on-premise, cloud or hybrid architectures.
• Validation support and documentation packages for regulated pharmaceutical environments.
Antares Vision Group combines track and trace software with line-level serialization, vision and aggregation expertise. This is especially relevant for projects that need to align hardware performance, data integrity, regulatory compliance and enterprise scalability in one validated solution.
Pharma Serialization Software, Traceability and Packaging Line Integration
A pharmaceutical track and trace system includes several interconnected topics. The following sections address common search terms and decision areas used by pharmaceutical manufacturers when evaluating serialization and traceability solutions.
Pharmaceutical serialization software
Pharmaceutical serialization software manages the creation, allocation, printing, verification and lifecycle status of serial numbers used on drug packaging. It is the foundation of pharma track and trace because every subsequent event depends on a correctly assigned and verified product identity.
Track and trace software
Track and trace software extends serialization beyond the packaging line. It captures aggregation relationships, manages serialized events, supports EPCIS or market-specific data exchange, connects with ERP/MES systems and enables regulatory reporting across sites and markets.
Serialization and aggregation
Serialization identifies the individual saleable unit. Aggregation links that unit to higher packaging levels such as bundles, cases and pallets. Together, serialization and aggregation enable efficient shipment verification, warehouse operations, recalls and supply chain event reporting.
Retrofit and revamp of serialization systems
Many pharmaceutical companies need to upgrade existing serialization lines rather than replace complete packaging equipment. Retrofit and revamp projects may involve new cameras, printers, controllers, aggregation workstations, software upgrades or migration to a more scalable site or enterprise architecture.
OEM integration
At line level, serialization and aggregation modules are often integrated into packaging machines. OEM cooperation can therefore be important for new lines, while the final pharmaceutical customer typically defines the preferred serialization technology, compliance requirements, data architecture and validation expectations.
EU FMD serialization
EU FMD serialization requires prescription medicine packs in scope to carry a unique identifier and anti-tampering device, with verification and decommissioning through the European and national repository system. Manufacturers selling in multiple regions often implement broader track and trace capabilities to address requirements beyond EU FMD.
DSCSA compliance
DSCSA compliance requires pharmaceutical supply chain stakeholders in the United States to support interoperable, electronic product tracing and verification. For manufacturers, this makes serialized data quality, aggregation accuracy, EPCIS-compatible exchange and partner connectivity critical elements of the track and trace architecture.
Frequently Asked Questions (FAQ)
A pharmaceutical track and trace system is a validated technology architecture that manages serialization, aggregation and traceability data for drug products. It connects packaging line hardware, software, ERP/MES systems, regulatory reporting and trading partner exchange to support product identification, verification and supply chain visibility.
Serialization assigns a unique identity to each saleable unit. Track and trace records what happens to that identity across packaging, aggregation, warehousing, shipping, verification and decommissioning events. Serialization is one component of a broader track and trace architecture.
Pharmaceutical serialization software manages serial number generation or import, allocation to production batches, print-and-verify operations, code status, exception handling and data exchange with higher-level systems. It ensures that each pack can be uniquely identified and controlled throughout its lifecycle.
Aggregation creates a digital parent-child relationship between serialized units and higher packaging levels such as bundles, cases and pallets. This allows operators and supply chain partners to scan a case or pallet and know which serialized units it contains.
EPCIS is a GS1 standard used to capture and exchange event data across the supply chain. In pharmaceutical track and trace, EPCIS-compatible event management can support standardized communication of serialization, aggregation, shipment and verification data between systems and trading partners.
L1 and L2 usually refer to machine and line-level control, including printers, cameras, reject systems and serialization stations. L3 manages serialization at site level across lines and operations. L4 manages enterprise-level serial number governance, ERP integration, multi-site coordination and regulatory connectivity.
EU FMD requires a unique identifier and anti-tampering device for medicinal products in scope, with verification and decommissioning through the repository system. Aggregation is not a general EU FMD requirement, but it is often implemented to support other regulations, DSCSA-related operations and logistics efficiency.
Evaluation usually involves serialization managers, packaging engineering, QA, IT/OT, supply chain, regulatory compliance and operations. OEMs and system integrators may be involved for line-level integration, while enterprise software and regulatory connectivity are typically governed by the pharmaceutical manufacturer, CMO/CDMO or MAH.
Yes. Serialization and aggregation systems can often be retrofitted or upgraded on existing packaging lines. Retrofit projects may include cameras, printers, controllers, reject systems, aggregation workstations, software migration, regulatory connectivity upgrades or integration with enterprise systems.
An integrated solution helps align line performance, data integrity, aggregation accuracy, regulatory compliance and enterprise scalability. This reduces the risk of disconnected systems and supports more reliable serialization data across packaging, site and supply chain operations.